期刊文献+

6-羟基多巴定向注射建立帕金森病大鼠模型的实验研究 被引量:19

Experimental study on establishment of PD's rats model by 6-OHDA directional injection
原文传递
导出
摘要 目的探讨立体定向间隔注射6-羟基多巴(6-OHDA)毁损黑质致密部(SNc)和中脑腹侧被盖(VTA)建立类似于人类帕金森病(PD)中晚期的PD大鼠模型方法。方法近交系Wistar大鼠50只,脑立体定向将6-OHDA注入大鼠右侧VTA及SNc,间隔两周,对阿朴吗啡(Apo)诱发旋转后旋转不明显或无稳定左侧旋转模型再次制模,并观察大鼠行为学改变,免疫组化检测黑质多巴胺(DA)能神经元的数量以及高效液相-荧光法检测黑质纹状体中DA含量的变化。结果(1)50只大鼠中有41只经APO诱导表现为恒定左侧旋转且结果稳定,旋转圈数>210r/30min,视为成功PD大鼠模型,部分大鼠伴有震颤、活动迟缓、嗅探、觅食、竖尾等异常行为改变,并且可持续存在16周;(2)免疫组化结果:PD大鼠模型毁损侧黑质区多巴胺能神经元较对侧及对照组减少大于90%;(3)PD大鼠右侧黑质纹状体中DA含量较左侧及对照组减少90%以上。结论6-OHDA毁损SNc及VTA间隔注射法可有效建立模拟人类PD中晚期的大鼠PD模型。 Objective To study the methods of establishing rat subjects with Parkinson's disease (PD) by injecting 6-hydrodopamine (6-OHDA) occasionally and steric directionally into SNc and VTA, which, is similar to human PD of middle-latter period. Methods Subject of ambiguousness of rotating after being induced to rotate or unstable left rotating subject was made again two weeks after cerebral steric directional injection of 6-OHDA into VTA in the right and SNC or 50 Wistar rats of inbred line. The changes of behavior, neurons' quantity if DA tested by immunohistochemistry and the level of dopamine in nigrostriatal system were observed. Results (1) 41 of rats showed steadily apormorphine-induced rotation(82%) and they could last for 16 weeks. The rotation rate was above 210 r/30 min, which were regard as success PD rats, parts of which displayed abnormal behaviors, such as moving stiffly, sniffing, seeking for food, railerection, et al. (2) The result of immunohistochemistry: neuron in damaged side of DA was reduced by more than 90% compared with that in the opposite side and control group. (3) The level of DA in PD rats' right nigrostriatal system was obviously reduced compared to that of the control and PD rats' left side. Conclusion Unilateral interval injection of 6-OHDA into the SNc and VTA can establish PD rat models steadily and effectively, which is similar to human PD of middle-latter period.
出处 《中华神经医学杂志》 CAS CSCD 2006年第3期244-247,257,共5页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(30270491) 广东省重大科技计划项目粤科基办(2000)25
关键词 帕金森病 6-羟基多巴 高效液相色谱法 免疫组化 大鼠 Parkinson's disease 6-hydroxydopamine High-performance liquid chromatography Immunohistochemistry Rat
  • 相关文献

参考文献19

  • 1Paxinos G, Watson C. The Rat Brain in Stereotatic Coordinates[M].Second Edition. USA: San Diego, Academic Press, 1998.36.
  • 2张旺明,徐如祥,蔡颖谦,张世忠,杜谋选.帕金森病大鼠模型尾壳核多巴胺D2受体活性变化研究[J].中华神经外科疾病研究杂志,2002,1(3):266-268. 被引量:8
  • 3李耀宇,舒斯云,包新民,吴文龙.大鼠纹状体边缘区与杏仁核和终纹床核之间相互联系的免疫组织化学研究[J].神经解剖学杂志,2000,16(3):265-268. 被引量:5
  • 4Ferro MM, Bellissimo MI, Anselmo-Franci JA, et al.Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: Histological, neurochemical, motor and memory alterations[J]. J Neurosci Methods, 2005, 148(1): 78-87.
  • 5Ossowska K, Wardas J, Smialowska M, et al. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?[J]. Eur J Neurosci, 2005,22(6): 1294-1304.
  • 6梁希彬,罗涌,卢峻,刘贤宇,张旺明,李丰桥,王晓民,韩济生.线刀损毁大鼠内侧前脑束建立部分损伤的帕金森病模型[J].神经解剖学杂志,2001,17(3):199-204. 被引量:4
  • 7Hsieh PF, Chia LG, Ni DR, et al. Behavior, neurochemistry and histology after intraaigral lipopolysaccharide injection [J].Neuroreport, 2002, 13(3): 277-280.
  • 8Jia RR, Gou YL, Ho LS, et al. Anti-apoptotic activity of Bak Foong Pills and its ingredients on 6-hydroxydopamine-induced neurotoxicity in PCI2 cells[J]. Cell Biol Int, 2005, 29(10): 835-842.
  • 9Honze C, Earl C, Sautter J, et al. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats [J]. Brain Res, 2005, 1052 (1):97-104.
  • 10Sun M, Kong L, Wang X, et al. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease[J]. Brain Res, 2005, 1052(2): 119-129.

二级参考文献19

  • 1张旺明,徐如祥,蔡颖谦,张世忠.6-羟多巴胺诱导帕金森病模型鼠黑质神经细胞凋亡的观察[J].中华老年医学杂志,2000,19(2):119-121. 被引量:13
  • 2[8]CASSARINO DS,FALL CP,SWERDLOW RH,et al.Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease[J].Biochem Biophys Acta,1997,1362(1):77-86.
  • 3[9]EBALLOS I,LAFON M,JAVOY AGID F,et al.Superoxide dismutase and Parkinson's disease[J].Lancet,1990,335(8696):1035-1036.
  • 4[10]GRUNBLATT E,MANDEL S,YOUDIM MB.MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies[J].J Neurol,247 Suppl(2):II95-102.
  • 5[1]ICHITANI Y,OKAMURA H,NAKAHARA D,et al.Biochemical and immunocytodchemical changes induced by intradtriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra[J].Exp Neurol,1994,130(2):269-278.
  • 6[3]HEIKKILA RE,SHAPIRO BS,DUVOISIN RC.Behavioral correlations between loss of dopamine nerve terminals,striatal (3H) spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats[J].Brain Res,1981,211:285-292.
  • 7[4]YOUDIM MB,GRUNBLATT E,MANDEL S.The pivotal role of iron in
  • 8[5]NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration Prospects for neuroprotection in Parkinson's disease with iron chelators[J].Ann N Y Acad Sci,1999,890:7-25.
  • 9[6]ILIC T,JOVANOVIC M,JOVICIC A,et al.Oxidative stress and Parkinson's disease[J].Vojnosanit Pregl,1998,55(5):463-468.
  • 10[7]LOTHARIUS J,DUGAN LL,O'MALLEY KL.Distinct mechanisms un-derlie neurotoxin-mediated cell death in cultured dopaminergic neurons[J].J Neurosci,1999,19(4):1284-1293.

共引文献18

同被引文献189

引证文献19

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部